1 completed, 1 withdrawn. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Withdrawn 1 |
| Phase 2 | 1 | Completed 1 |
Follow Olfactory Disorder: new trials by email Literature Review of Olfactory Disorder trials Research Report on Olfactory Disorder
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Simvastatin Nasal Rinses for the Treatment of COVID-19 Mediated Dysomsia Simvastatin - Olfactory Disorder, COVID-19 | Phase 1 | Withdrawn | Washington University School of Medicine | 2023-05-01 | 2023-06-12 | |
| Stellate Ganglion Block for COVID-19-Induced Olfactory Dysfunction Stellate Ganglion Block - Anosmia, Hyposmia | Phase 1 / Phase 2 | Completed | Washington University School of Medicine | 20 | 2022-09-01 | 2026-02-12 |
COVID-19 (2) · Anosmia (1) · Olfaction Disorders (1)
Coronaviridae Infections (2) · Coronavirus Infections (2) · Infections (2) · Lung Diseases (2) · Nidovirales Infections (2) · Pneumonia (2) · Pneumonia, Viral (2) · RNA Virus Infections (2) · Respiratory Tract Diseases (2) · Respiratory Tract Infections (2) · Virus Diseases (2) · Nervous System Diseases (1) · Neurologic Manifestations (1) · Pathological Conditions, Signs and Symptoms (1) · Sensation Disorders (1)
Mepivacaine (1) · Simvastatin (1)
Washington University School of Medicine (2)
United States (1)